Trisalus Life Sciences Investor Relations Material

Trisalus Life Sciences Inc is an oncology company focused on integrating novel delivery technology with immunotherapy to transform the treatment of patients with liver and pancreatic tumors. The company's approach combines innovative drug delivery systems with clinical-stage investigational immunotherapies, aiming to address the unique challenges of treating tumors in the liver and pancreas. These challenges include overcoming the high intratumoral pressure and immunosuppressive environment that can limit the efficacy of traditional treatments. Trisalus Life Sciences is committed to advancing its platform to improve the therapeutic outcomes for patients facing these difficult-to-treat cancers. The company is headquartered in Denver, Colorado, and its shares are listed on the Nasdaq.